Cost effective & Value-based Evidence Development Abstract: One of the more significant barriers to obtaining coverage and reimbursement for a new or established advanced diagnostic is the high cost of the evidence development establishing clinical relevance. Creative approaches and a multi-prong strategy are critical to successfully balance evidence development with budget limitations and internal/investor pressure Read more »
